- AAPAA
American Academy of Psychiatrists in Alcoholism and Addiction - ABMS
American Board of Medical Specialties - ABPN
American Board of Psychiatry and Neurology - ACTH
adrenocorticotrophic hormone - ADAMHA
Alcohol, Drug Abuse, and Mental Health Administration - ADD
Antiepileptic Drug Development Program - ADEPT
Alcohol and Drug Education for Physician Training - AFDC
Aid to Families with Dependent Children - AIDS
acquired immune deficiency syndrome - ALS
amyotrophic lateral sclerosis (Lou Gehrig’s disease) - AMBHA
American Managed Behavioral Healthcare Association - AMERSA
Association for Medical Education and Research in Substance Abuse - AMP
adenosine 3’5′-monophosphate - ASAM
American Society of Addiction Medicine - ATC
addiction training center - AZT
zidovudine - BDC
BioDevelopment Corporation - BJS
Bureau of Justice Statistics - BLS
Bureau of Labor Statistics - BSMD
Biobehavioral Sciences and Mental Disorders - CALDATA
California Drug and Alcohol Treatment Assessment - CASA
Center on Addiction and Substance Abuse - CBO
Congressional Budget Office - CDC
Centers for Disease Control and Prevention - CDDA
Commission on Medicines for Treatment of Drug Dependence and Abuse - CDER
Center for Drug Evaluation and Research - CDP
chemical dependency programs - CME
continuing medical education - CMHS
Center for Mental Health Services - CNS
central nervous system - CPDD
College on Problems of Drug Dependence - CRADAs
cooperative research and development agreements - CRS
Congressional Research Service - CSA
Controlled Substances Act - CSAP
Center for Substance Abuse Prevention - CSAT
Center for Substance Abuse Treatment - CTDP
Cocaine Treatment Discovery Program - DAWN
Drug Abuse Warning Network - DD
drug-discrimination test - DEA
Drug Enforcement Agency - DHHS
U.S. Department of Health and Human Services - DPC-PTR
Drug Price Competition and Patent Term Restoration Act - DSRS
Drug Services Research Survey - DVA
Department of Veterans Affairs - FDA
Food and Drug Administration - FDCA
Federal Food, Drug, and Cosmetic Act - FTEs
full-time equivalent personnel - FY
fiscal year - GAO
General Accounting Office - HIV
human immunodeficiency virus - HMO
health maintenance organization - HRSA
Health Resources and Services Administration - IDU
injecting drug-user - IND
investigational new drug - IOM
Institute of Medicine - IRB
institutional review board - K20
Scientist Development Award for Clinicians - K21
Scientist Development Award - LAAM
levo-alpha-acetylmethadol (trade name ORLAAM) - LMA
locomotor-activity test - LRP
Loan Repayment Program - MARC
Minority Access to Research Careers - MDD
Medications Development Division - MDMA
Methylenedioxymethamphetamine (“ecstacy”) - MSH
melanocyte-stimulating hormone - NAS
National Academy of Sciences - NASADAD
National Association of State Alcohol and Drug Abuse Directors, Inc. - NATA
Narcotic Addict Treatment Act - NCDDG-AIDS
National Cooperative Drug Discovery Groups on Acquired Immune Deficiency Syndrome - NCI
National Cancer Institute - NCJA
National Criminal Justice Association - NDA
new drug application - NDATUS
National Drug and Alcoholism Treatment Survey - NIAAA
National Institute on Alcohol Abuse and Alcoholism Administration - NIAID
National Institute of Allergy and Infectious Diseases - NIDA
National Institute on Drug Abuse - NIH
National Institutes of Health - NRC
National Research Council - NRSA
National Research Service Awards - ODF
out-patient drug-free - ONDCP
Office of National Drug Control Policy - OPRR
Office of Protection from Research Risks - ORLAAM™
levo-alpha-acetylmethadol (LAAM) - OTA
Office of Technology Assessment - PBMs
pharmaceutical benefit managers - PCP
phencyclidine - PhRMA
Pharmaceutical Research and Manufacturers of America - PHS
Public Health Service - PMA
Pharmaceutical Manufacturers Association - POMC
pro-opiomelanocortin - R&D
research and development - R01
investigator-initiated grants - R18
research-demonstration grants - SA
self-administration test - SADAP
State Alcohol and Drug Abuse Profile - SAMHSA
Substance Abuse and Mental Health Services Administration - SSI
Supplemental Security Income - TB
tuberculosis - Tcs
therapeutic communities - TOPS
Treatment Outcome Prospective Study - TRUs
treatment research units - VA
Department of Veterans Affairs - WHO
World Health Organization
